Evidence map›Paper›PMID 33889711›Full record

ArticleInternational journal of cardiology. Heart & vasculature2021

Efficacy and safety of percutaneous mitral balloon valvotomy in patients with mitral stenosis: A systematic review and meta-analysis.

Anan A Abu Rmilah, Mahmoud A Tahboub, Adham K Alkurashi, Suhaib A Jaber, Asil H Yagmour, Deema Al-Souri, Bradley R Lewis, Vuyisile T Nkomo, Patricia J Erwin, Guy S Reeder

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Anan A Abu RmilahWilliam J. von Liebig Center for Transplantation and Clinical Regeneration Mayo Clinic, Rochester, MN, USA.
Mahmoud A TahboubWilliam J. von Liebig Center for Transplantation and Clinical Regeneration Mayo Clinic, Rochester, MN, USA.
Adham K AlkurashiDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Suhaib A JaberDepartment of Internal Medicine, Al Hamadi Hospital, Riyadh, Saudi Arabia.
Asil H YagmourAl Quds University School of Medicine, Palestine.
Deema Al-SouriDepartment of Internal Medicine, Med Star Washington Hospital Center, Washington DC, USA.
Bradley R LewisDepartment of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Vuyisile T NkomoDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Patricia J ErwinDepartment of Library Services, Mayo Clinic, Rochester, MN, USA.
Guy S ReederDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic · USMayo Clinic in Arizona · USAl-Quds University · PSMayo Clinic in Florida · USMedStar Washington Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPercutaneous mitral balloon valvotomy PMBV is an acceptable alternative to Mitral valve surgery for patients with mitral stenosis. The purpose of this study was to explore the immediate results of PMBV with respect to echocardiographic changes, outcomes, and complications, using a

methodsMEDLINE, and EMBASE databases were searched (01/2012 to 10/2018) for original research articles regarding the efficacy and safety of PMBV. Two reviewers independently screened references for inclusion and abstracted data including article details and echocardiographic parameters before and 24-72 h after PMBV, follow-up duration, and acute complications. Disagreements were resolved by third adjudicator. Quality of all included studies was evaluated using the Newcastle-Ottawa Scale NOS.

results44/990 references met the inclusion criteria representing 6537 patients. Our findings suggest that PMBV leads to a significant increase in MVA (MD = 0.81 cm

conclusionPMBV represents a successful approach for patients with mitral stenosis as evidenced by improvement in echocardiographic parameters and low rate of complications.

Indexed as

AF, Atrial fibrillationAHA/ACC, American Heart Association (AHA) and American College of Cardiology (ACC)EchocardiographyLAD, Left atrial diameterLAP, Left atrial pressureLV EDP, Left ventricle end-diastolic pressureLV EDV, Left ventricle end-diastolic volumeLV ESP, Left ventricle end-systolic pressureLV ESV, Left ventricle end-systolic volumeMACCE, Major adverse cardiovascular and cerebrovascular eventsMD, Mean differenceMitral stenosisMitral valve surgeryMPG, Mitral pressure gradientMR, Mitral regurgitationMS, Mitral stenosisMVA, Mitral valve areaNOS, New castle Ottawa scalePercutaneous balloon mitral valvotomyPercutaneous balloon mitral valvuloplastyPMBV, percutaneous mitral balloon valvotomySR, sinus rhythm

Identifiers

PMID33889711
PMCPMC8050729
OpenAlexW3145287161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.